Heska (HSKA) Hits New 52-Week Low at $70.00
Heska Corp (NASDAQ:HSKA) reached a new 52-week low during mid-day trading on Tuesday . The company traded as low as $70.00 and last traded at $70.04, with a volume of 64477 shares changing hands. The stock had previously closed at $72.09.
Several equities research analysts have recently weighed in on the company. B. Riley reissued a “hold” rating and set a $96.50 target price on shares of Heska in a research report on Friday, October 27th. BidaskClub downgraded Heska from a “hold” rating to a “sell” rating in a research report on Saturday, December 9th. Raymond James Financial restated a “buy” rating on shares of Heska in a research report on Monday, December 4th. ValuEngine downgraded Heska from a “hold” rating to a “sell” rating in a research report on Friday, February 2nd. Finally, Sidoti upgraded Heska from a “neutral” rating to a “buy” rating and set a $94.00 price target for the company in a research report on Monday. Three analysts have rated the stock with a sell rating, one has issued a hold rating and five have issued a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and a consensus target price of $110.08.
The company has a market cap of $501.42, a PE ratio of 32.48, a price-to-earnings-growth ratio of 1.82 and a beta of 0.67.
Institutional investors and hedge funds have recently bought and sold shares of the business. Neuberger Berman Group LLC increased its position in shares of Heska by 34.2% during the third quarter. Neuberger Berman Group LLC now owns 603,469 shares of the medical research company’s stock worth $53,160,000 after purchasing an additional 153,895 shares in the last quarter. Vanguard Group Inc. grew its holdings in shares of Heska by 31.7% during the 2nd quarter. Vanguard Group Inc. now owns 461,841 shares of the medical research company’s stock worth $47,141,000 after purchasing an additional 111,232 shares during the period. State Street Corp grew its holdings in shares of Heska by 12.7% during the 2nd quarter. State Street Corp now owns 195,970 shares of the medical research company’s stock worth $19,998,000 after purchasing an additional 22,053 shares during the period. Atlantic Trust Group LLC purchased a new position in shares of Heska during the 3rd quarter worth $16,059,000. Finally, Dimensional Fund Advisors LP grew its holdings in shares of Heska by 26.0% during the 3rd quarter. Dimensional Fund Advisors LP now owns 151,460 shares of the medical research company’s stock worth $13,342,000 after purchasing an additional 31,286 shares during the period. Institutional investors own 80.13% of the company’s stock.
ILLEGAL ACTIVITY NOTICE: This piece was originally reported by Watch List News and is owned by of Watch List News. If you are viewing this piece on another website, it was illegally stolen and republished in violation of United States and international copyright and trademark law. The legal version of this piece can be accessed at https://www.watchlistnews.com/heska-hska-hits-new-52-week-low-at-70-00/1852943.html.
Heska Corporation sells veterinary diagnostic and specialty products. The Company operates through two segments: Core Companion Animal Health (CCA) and Other Vaccines, Pharmaceuticals and Products (OVP). The CCA segment includes, primarily for canine and feline use, blood testing instruments and supplies, digital imaging products, software and services, local and cloud-based data services, allergy testing and immunotherapy, and single use offerings, such as in-clinic diagnostic tests and heartworm preventive products.
Receive News & Ratings for Heska Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Heska and related companies with MarketBeat.com's FREE daily email newsletter.